跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-103
首页
药物
R-103
R-103
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
US 8097251 B2
申请人: MUYLDERMANS SERGE
优先权: 2004
US
7 件公开
2-iminopyrrolidine derivatives
US 7244730 B2
申请人: EISAI CO LTD
优先权: 2001
CN
US
4 件公开
Organic light-emitting device
US 11024818 B2
申请人: CAMBRIDGE DISPLAY TECH LTD
优先权: 2014
CN
US
2 件公开
ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE
EP 3731329 A1
申请人: DAIKIN IND LTD
优先权: 2018
CN
EP
2 件公开
Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
US 8992945 B2
申请人: LEE PING I
优先权: 2007
US
2 件公开
ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE
EP 3703173 A4
申请人: DAIKIN IND LTD
优先权: 2017
EP
2 件公开
Compound inhibiting in vivo phosphorous transport and medicine containing the same
US 2006217426 A1
申请人: KIRIN BREWERY
优先权: 2003
US
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
US 2006034773 A1
申请人: GIOVENZANA GIOVANNI B
优先权: 2005
US
新型proNGF突变体及其在生产β-NGF中的用途
CN 104203264 B
申请人: 瓦克化学有限公司
优先权: 2012
CN
NOVEL PRO- AND CODRUG DERIVATIVES FOR NANOPARTICLE DELIVERY OF SELECT ANTICANCER AGENTS FORMED USING RAPIDLY CLEAVABLE PHENOLIC ESTER BRIDGES
US 2015119388 A1
申请人: PHILADELPHIA CHILDREN HOSPITAL
优先权: 2013
US
第 1 / 2 页
上一页
下一页
药物
反馈